Portfolio-to-Protocol Alignment
Carry strategy, assumptions, and evidence from program planning into protocol-level decisions without rework.
Standardize trial design and study-startup workflows across programs while preserving traceability and local context.
€59,280
Annual Capacity Value
€35,280
Net Annual Value
0.3 FTE
FTE Capacity
4.9 months
Payback
WORKFLOWS
Pharma teams lose time when global design decisions, evidence updates, country feedback, and document revisions drift across siloed tools. TrialStack keeps program work aligned from protocol strategy through start-up execution.
Carry strategy, assumptions, and evidence from program planning into protocol-level decisions without rework.
Keep clinical, regulatory, medical writing, and operations review in one governed path with clear ownership and rationale.
Generate protocol and submission documents from current approved decisions instead of fragmented source drafts.
Track country and site feedback, changes, and actions against a shared source of truth before activation.
Built on trusted standards
Structured around the standards that guide modern clinical development.
TrialStack supports different operating models, but the platform value stays the same: clearer decisions, shared context, governed workflows, and less avoidable rework.
Pricing
Start with one active trial, then scale into multiple studies, larger teams, higher AI usage, stronger governance controls, and priority support as your study-startup work grows.
Ignite
For small teams launching a first trial who need core governance, evidence, and document controls.
Accelerate
For teams managing multiple active studies that need more capacity, stronger governance, and faster support.
Scale
For enterprise teams running larger study portfolios with custom limits, identity controls, and dedicated support.
Get started
Talk through your trial design, evidence review, document generation, and start-up workflows, then choose the Studio, Loop, or Catalyst path that fits your team.